The study of endocrine cancers and oncology focuses on tumors affecting hormone-producing glands such as the thyroid, pancreas, and adrenal glands. Malignancies like pancreatic neuroendocrine tumors and medullary thyroid carcinoma require specialized treatment approaches due to their complex interaction with hormonal regulation. Advances in molecular oncology have led to targeted therapies that inhibit abnormal signaling pathways, improving survival rates. Immunotherapy is also gaining traction as a promising approach for endocrine cancers, particularly in cases resistant to traditional chemotherapy. Early detection through biomarker screening and imaging technologies enhances treatment efficacy. Ongoing research continues to refine therapeutic options, providing hope for improved patient outcomes.
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre diabetes and type 2) with integrative medicine
F Buck Willis, Christian College of Medicine, Belize
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : AI receptor binding studies reveal GPR146 conformational states across diabetic phenotypes: Analysis of C peptide and insulin interactions in cholesterol metabolism cortisol regulation and the vitamin D renin angiotensin axis
David Petch, utR Biotech, Canada
Title : Comparative outcomes of antihypertensive therapy in black vs non hispanic white patients with hypertension and cardiovascular disease
Anil Harrison, Midwestern University, United States